Inventor
HABERMANN PAUL
DE34 patents
⚠️ This page may combine multiple inventors who share the name “HABERMANN PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
14 patentsUS5359035AOct 25, 1994
Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
HOECHST AG108 citations96
US6875589B1Apr 5, 2005
Mini-proinsulin, its preparation and use
HOECHST AG32 citations92
US5496924AMar 5, 1996
Fusion protein comprising an interleukin-2 fragment ballast portion
HOECHST AG45 citations87
US5866371AFeb 2, 1999
Process for using the yeast ADH II promoter system for the production of heterologous proteins in high yields
HOECHST AG18 citations81
US5095092AMar 10, 1992
Process for the isolation and purification of hirudin
HOECHST AG19 citations80
US5538946AJul 23, 1996
Hirudin derivatives with delayed action
HOECHST AG8 citations73
US5316947AMay 31, 1994
Synthetic isohirudins with improved stability
HOECHST AG4 citations73
US5298603AMar 29, 1994
GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
HOECHST AG8 citations73
US5286714AFeb 15, 1994
Synthetic isohirudins with improved stability
HOECHST AG4 citations73
US5180668AJan 19, 1993
Hirudin derivative
HOECHST AG11 citations73
US5093322AMar 3, 1992
Tick-derived amblyommin and method of antithrombin therapy
HOECHST AG11 citations70
US5616476AApr 1, 1997
Synthetic isohirudins with improved stability
HOECHST AG3 citations62
US5322926AJun 21, 1994
Isohirudins
HOECHST AG5 citations62
US5866399AFeb 2, 1999
Process for inactivating carboxypeptidase Y in hirudin-containing culture broths
HOECHST AG1 citations50
AVENTIS PHARMA GMBH
5 patentsUS6221633B1Apr 24, 2001
Insulin derivatives having a rapid onset of action
AVENTIS PHARMA GMBH193 citations98
US6221837B1Apr 24, 2001
Insulin derivatives with increased zinc binding
AVENTIS PHARMA GMBH45 citations92
US6686177B1Feb 3, 2004
Insulin analogs with enhanced zinc binding
AVENTIS PHARMA GMBH21 citations89
US6534288B1Mar 18, 2003
C peptide for improved preparation of insulin and insulin analogs
AVENTIS PHARMA GMBH12 citations73
US6531294B1Mar 11, 2003
Preparation of pancreatic procarboxypeptidase B, isoforms and muteins thereof and their use
AVENTIS PHARMA GMBH3 citations63
SANOFI AVENTIS DEUTSCHLAND
4 patentsUS8048854B2Nov 1, 2011
Amidated insulin glargine
SANOFI AVENTIS DEUTSCHLAND33 citations91
US7939293B2May 10, 2011
Method for producing carboxy-terminal-amidified peptides
SANOFI AVENTIS DEUTSCHLAND26 citations89
US7455987B1Nov 25, 2008
Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture medium
SANOFI AVENTIS DEUTSCHLAND6 citations61
US7638618B2Dec 29, 2009
Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
SANOFI AVENTIS DEUTSCHLAND0 citations52
HABERMANN PAUL
3 patentsUS8633156B2Jan 21, 2014
Insulin derivatives having an extremely delayed time-action profile
HABERMANN PAUL18 citations81
US9644017B2May 9, 2017
Insulin derivatives having an extremely delayed time-action profile
HABERMANN PAUL0 citations49
US8410048B2Apr 2, 2013
Method for producing insulin analogs having a dibasic B chain terminus
HABERMANN PAUL0 citations38